BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

NCT07009002 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphoma

Interventions

BIOLOGICAL: CAR19TIF cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Chinese PLA General Hospital